NF-κB function in B lymphocytes

Immunological Reviews

Volumn 246, Issue 1, 2012, Pages 254-271

  Kaileh, Mary ^a   Sen, Ranjan ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

B lymphocytes; BCR; Development; Function; NF B

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; BACTERIUM LIPOPOLYSACCHARIDE; BIM PROTEIN; CARMA1 PROTEIN; CD19 ANTIGEN; CD40 ANTIGEN; CHEMOKINE RECEPTOR CCR7; COMPLEMENT COMPONENT C3D RECEPTOR; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE C BETA; PROTEIN MCL 1; PROTEIN P105; PROTEIN P50; PROTEIN P52; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

APOPTOSIS; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CROSS LINKING; CYTOLOGY; DNA STRAND BREAKAGE; ENHANCER REGION; ENZYME ACTIVATION; GENE ACTIVATION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; CELL SURVIVAL; HUMANS; NF-KAPPA B;

EID: 84858712873     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2012.01106.x     Document Type: Review

References (182)

1. Dorshkind K, Montecino-Rodriguez E. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat Rev Immunol 2007;7:213-219.
2. Abarrategui I, Krangel MS. Germline transcription: a key regulator of accessibility and recombination. Adv Exp Med Biol 2009;650:93-102.
3. Hardy RR, Kincade PW, Dorshkind K. The protean nature of cells in the B lymphocyte lineage. Immunity 2007;26:703-714.
4. Jhunjhunwala S, van Zelm MC, Peak MM, Murre C. Chromatin architecture and the generation of antigen receptor diversity. Cell 2009;138:435-448.
5. Luning Prak ET, Monestier M, Eisenberg RA. B-cell receptor editing in tolerance and autoimmunity. Ann N Y Acad Sci 2011;1217:96-121.
6. Nemazee D. Receptor selection in B and T lymphocytes. Annu Rev Immunol 2000;18:19-51.
7. Allman D, Pillai S. Peripheral B-cell subsets. Curr Opin Immunol 2008;20:149-157.
8. Casola S. Control of peripheral B-cell development. Curr Opin Immunol 2007;19:143-149.
9. Gerondakis S, Siebenlist U. Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb Perspect Biol 2010;2:a000182.
10. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009;27:693-733.
11. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986. 46: 705-716. J Immunol 2006;177:7485-7496.
12. Lenardo M, Pierce JW, Baltimore D. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 1987;236:1573-1577.
13. Inlay M, Alt FW, Baltimore D, Xu Y. Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation. Nat Immunol 2002;3:463-468.
14. Xu Y, Davidson L, Alt FW, Baltimore D. Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement. Immunity 1996;4:377-385.
15. Baeuerle PA, Baltimore D. A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. Genes Dev 1989;3:1689-1698.
16. Ghosh S, Gifford AM, Riviere LR, Tempst P, Nolan GP, Baltimore D. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell 1990;62:1019-1029.
17. Nolan GP, Ghosh S, Liou HC, Tempst P, Baltimore D. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell 1991;64:961-969.
18. Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 1995;80:321-330.
19. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995;376:167-170.
20. Horwitz BH, Scott ML, Cherry SR, Bronson RT, Baltimore D. Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. Immunity 1997;6:765-772.
21. Senftleben U, Li ZW, Baud V, Karin M. IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity 2001;14:217-230.
22. Inlay MA, Tian H, Lin T, Xu Y. Important roles for E protein binding sites within the immunoglobulin kappa chain intronic enhancer in activating Vkappa Jkappa rearrangement. J Exp Med 2004;200:1205-1211.
23. Das S, Nikolaidis N, Nei M. Genomic organization and evolution of immunoglobulin kappa gene enhancers and kappa deleting element in mammals. Mol Immunol 2009;46:3171-3177.
24. Fitzsimmons SP, Bernstein RM, Max EE, Skok JA, Shapiro MA. Dynamic changes in accessibility, nuclear positioning, recombination, and transcription at the Ig kappa locus. J Immunol 2007;179:5264-5273.
25. Goldmit M, et al. Epigenetic ontogeny of the Igk locus during B-cell development. Nat Immunol 2005;6:198-203.
26. Grawunder U, Haasner D, Melchers F, Rolink A. Rearrangement and expression of kappa light chain genes can occur without mu heavy chain expression during differentiation of pre-B-cells. Int Immunol 1993;5:1609-1618.
27. Novobrantseva TI, Martin VM, Pelanda R, Muller W, Rajewsky K, Ehlich A. Rearrangement and expression of immunoglobulin light chain genes can precede heavy chain expression during normal B-cell development in mice. J Exp Med 1999;189:75-88.
28. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 2002;9:625-636.
29. Hendriks RW, Middendorp S. The pre-BCR checkpoint as a cell-autonomous proliferation switch. Trends Immunol 2004;25:249-256.
30. Werner M, Hobeika E, Jumaa H. Role of PI3K in the generation and survival of B-cells. Immunol Rev 2010;237:55-71.
31. - pre-B-cells. Int Immunol 2005;17:815-825.
32. Derudder E, et al. Development of immunoglobulin lambda-chain-positive B-cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappaB signals. Nat Immunol 2009;10:647-654.
33. Bredemeyer AL, et al. DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature 2008;456:819-823.
34. Claudio E, Brown K, Siebenlist U. NF-kappaB guides the survival and differentiation of developing lymphocytes. Cell Death Differ 2006;13:697-701.
35. Gerondakis S, et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 2006;25:6781-6799.
36. Kaisho T, et al. IkappaB kinase alpha is essential for mature B-cell development and function. J Exp Med 2001;193:417-426.
37. Kim S, La Motte-Mohs RN, Rudolph D, Zuniga-Pflucker JC, Mak TW. The role of nuclear factor-kappaB essential modulator (NEMO) in B-cell development and survival. Proc Natl Acad Sci U S A 2003;100:1203-1208.
38. Pasparakis M, Schmidt-Supprian M, Rajewsky K. IkappaB kinase signaling is essential for maintenance of mature B-cells. J Exp Med 2002;196:743-752.
39. Feng B, Cheng S, Pear WS, Liou HC. NF-kB inhibitor blocks B-cell development at two checkpoints. Med Immunol 2004;3:1.
40. Goudeau B, et al. IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival. Proc Natl Acad Sci U S A 2003;100:15800-15805.
41. Igarashi H, Baba Y, Nagai Y, Jimi E, Ghosh S, Kincade PW. NF-kappaB is dispensable for normal lymphocyte development in bone marrow but required for protection of progenitors from TNFalpha. Int Immunol 2006;18:653-659.
42. Johnson K, et al. Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity 2008;28:335-345.
43. Ma S, Pathak S, Trinh L, Lu R. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood 2008;111:1396-1403.
44. Ma S, Turetsky A, Trinh L, Lu R. IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B-cell development. J Immunol 2006;177:7898-7904.
45. Grumont RJ, Gerondakis S. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J Exp Med 2000;191:1281-1292.
46. Klug CA, et al. The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes. Genes Dev 1994;8:678-687.
47. Muljo SA, Schlissel MS. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B-cell lines. Nat Immunol 2003;4:31-37.
48. Scherer DC, Brockman JA, Bendall HH, Zhang GM, Ballard DW, Oltz EM. Corepression of RelA and c-rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytes. Immunity 1996;5:563-574.
49. Guo F, Tanzer S, Busslinger M, Weih F. Lack of nuclear factor-kappa B2/p100 causes a RelB-dependent block in early B lymphopoiesis. Blood 2008;112:551-559.
50. Weih F, Durham SK, Barton DS, Sha WC, Baltimore D, Bravo R. p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice. J Exp Med 1997;185:1359-1370.
51. Alt FW, Enea V, Bothwell AL, Baltimore D. Activity of multiple light chain genes in murine myeloma cells producing a single, functional light chain. Cell 1980;21:1-12.
52. Chen J, Alt FW. Gene rearrangement and B-cell development. Curr Opin Immunol 1993;5:194-200.
53. Cadera EJ, Wan F, Amin RH, Nolla H, Lenardo MJ, Schlissel MS. NF-kappaB activity marks cells engaged in receptor editing. J Exp Med 2009;206:1803-1816.
54. Verkoczy L, et al. A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity 2005;22:519-531.
55. Claudio E, Saret S, Wang H, Siebenlist U. Cell-autonomous role for NF-kappa B in immature bone marrow B-cells. J Immunol 2009;182:3406-3413.
56. Enzler T, et al. Alternative and classical NF-kappa B signaling retain autoreactive B-cells in the splenic marginal zone and result in lupus-like disease. Immunity 2006;25:403-415.
57. Asano J, et al. The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells. Leukemia 2011;25:1182-1188.
58. Woodland RT, et al. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 2008;111:750-760.
59. Rowland SL, Leahy KF, Halverson R, Torres RM, Pelanda R. BAFF receptor signaling aids the differentiation of immature B-cells into transitional B-cells following tonic BCR signaling. J Immunol 2010;185:4570-4581.
60. Xue L, et al. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B-cells. Nat Immunol 2003;4:857-865.
61. Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B-cells. J Exp Med 2003;198:1119-1126.
62. Oliver PM, Vass T, Kappler J, Marrack P. Loss of the proapoptotic protein, Bim, breaks B-cell anergy. J Exp Med 2006;203:731-741.
63. Takeuchi O, Fisher J, Suh H, Harada H, Malynn BA, Korsmeyer SJ. Essential role of BAX, BAK in B-cell homeostasis and prevention of autoimmune disease. Proc Natl Acad Sci U S A 2005;102:11272-11277.
64. Cancro MP, Kearney JF. B-cell positive selection: road map to the primary repertoire? J Immunol 2004;173:15-19.
65. Edry E, Melamed D. Receptor editing in positive and negative selection of B lymphopoiesis. J Immunol 2004;173:4265-4271.
66. Grossmann M, Metcalf D, Merryfull J, Beg A, Baltimore D, Gerondakis S. The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects. Proc Natl Acad Sci U S A 1999;96:11848-11853.
67. Grossmann M, O'Reilly LA, Gugasyan R, Strasser A, Adams JM, Gerondakis S. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J 2000;19:6351-6360.
68. Schram BR, et al. B-cell receptor basal signaling regulates antigen-induced Ig light chain rearrangements. J Immunol 2008;180:4728-4741.
69. Tze LE, et al. Basal immunoglobulin signaling actively maintains developmental stage in immature B-cells. PLoS Biol 2005;3:e82.
70. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three nonproliferative immature splenic B-cell subsets reveals multiple selection points during peripheral B-cell maturation. J Immunol 2001;167:6834-6840.
71. Bell SE, et al. PLCgamma2 regulates Bcl-2 levels and is required for survival rather than differentiation of marginal zone and follicular B-cells. Eur J Immunol 2004;34:2237-2247.
72. Cancro MP, Sah AP, Levy SL, Allman DM, Schmidt MR, Woodland RT. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B-cell development. Int Immunol 2001;13:1501-1514.
73. Doody GM, et al. Signal transduction through Vav-2 participates in humoral immune responses and B-cell maturation. Nat Immunol 2001;2:542-547.
74. Fruman DA, et al. Impaired B-cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 1999;283:393-397.
75. Jumaa H, Wollscheid B, Mitterer M, Wienands J, Reth M, Nielsen PJ. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 1999;11:547-554.
76. Pappu R, et al. Requirement for B-cell linker protein (BLNK) in B-cell development. Science 1999;286:1949-1954.
77. Suzuki H, et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 1999;283:390-392.
78. Wen R, et al. Phospholipase Cgamma2 provides survival signals via Bcl2 and A1 in different subpopulations of B-cells. J Biol Chem 2003;278:43654-43662.
79. Yamazaki T, Takeda K, Gotoh K, Takeshima H, Akira S, Kurosaki T. Essential immunoregulatory role for BCAP in B-cell development and function. J Exp Med 2002;195:535-545.
80. Jun JE, et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 2003;18:751-762.
81. Newton K, Dixit VM. Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr Biol 2003;13:1247-1251.
82. Ruefli-Brasse AA, French DM, Dixit VM. Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase. Science 2003;302:1581-1584.
83. Ruland J, et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 2001;104:33-42.
84. Ruland J, Duncan GS, Wakeham A, Mak TW. Differential requirement for Malt1 in T and B-cell antigen receptor signaling. Immunity 2003;19:749-758.
85. Lin X, Wang D. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin Immunol 2004;16:429-435.
86. Thome M, Charton JE, Pelzer C, Hailfinger S. Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol 2010;2:a003004.
87. Andrews SF, Rawlings DJ. Transitional B-cells exhibit a B-cell receptor-specific nuclear defect in gene transcription. J Immunol 2009;182:2868-2878.
88. Castro I, et al. B-cell receptor-mediated sustained c-Rel activation facilitates late transitional B-cell survival through control of B-cell activating factor receptor and NF-kappaB2. J Immunol 2009;182:7729-7737.
89. Sen R. Control of B lymphocyte apoptosis by the transcription factor NF-kappaB. Immunity 2006;25:871-883.
90. Chung JB, Baumeister MA, Monroe JG. Cutting edge: differential sequestration of plasma membrane-associated B-cell antigen receptor in mature and immature B-cells into glycosphingolipid-enriched domains. J Immunol 2001;166:736-740.
91. Pierce SK. Lipid rafts and B-cell activation. Nat Rev Immunol 2002;2:96-105.
92. Sproul TW, Malapati S, Kim J, Pierce SK. Cutting edge: B-cell antigen receptor signaling occurs outside lipid rafts in immature B-cells. J Immunol 2000;165:6020-6023.
93. Smith SH, Cancro MP. Cutting edge: B-cell receptor signals regulate BLyS receptor levels in mature B-cells and their immediate progenitors. J Immunol 2003;170:5820-5823.
94. Hoek KL, Carlesso G, Clark ES, Khan WN. Absence of mature peripheral B-cell populations in mice with concomitant defects in B-cell receptor and BAFF-R signaling. J Immunol 2009;183:5630-5643.
95. Schiemann B, et al. An essential role for BAFF in the normal development of B-cells through a BCMA-independent pathway. Science 2001;293:2111-2114.
96. Thompson JS, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001;293:2108-2111.
97. Thompson JS, et al. BAFF binds to the tumor necrosis factor receptor-like molecule B-cell maturation antigen and is important for maintaining the peripheral B-cell population. J Exp Med 2000;192:129-135.
98. Yan M, Marsters SA, Grewal IS, Wang H, Ashkenazi A, Dixit VM. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol 2000;1:37-41.
99. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B-cells by inducible gene targeting results in rapid cell death. Cell 1997;90:1073-1083.
100. Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 2004;117:787-800.
101. Grande SM, Bannish G, Fuentes-Panana EM, Katz E, Monroe JG. Tonic B-cell and viral ITAM signaling: context is everything. Immunol Rev 2007;218:214-234.
102. Srinivasan L, et al. PI3 kinase signals BCR-dependent mature B-cell survival. Cell 2009;139:573-586.
103. Claudio E, Brown K, Park S, Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B-cells. Nat Immunol 2002;3:958-965.
104. Kayagaki N, et al. BAFF/BLyS receptor 3 binds the B-cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 2002;17:515-524.
105. Franzoso G, et al. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med 1998;187:147-159.
106. Weih DS, Yilmaz ZB, Weih F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol 2001;167:1909-1919.
107. Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003;426:671-676.
108. Pham LV, et al. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-kappaB-inducing kinase while activating both canonical and alternative nuclear factor-kappaB pathways. Blood 2011;117:200-210.
109. Shinners NP, et al. Bruton's tyrosine kinase mediates NF-kappa B activation and B-cell survival by B-cell-activating factor receptor of the TNF-R family. J Immunol 2007;179:3872-3880.
110. Sasaki Y, et al. Canonical NF-kappaB activity, dispensable for B-cell development, replaces BAFF-receptor signals and promotes B-cell proliferation upon activation. Immunity 2006;24:729-739.
111. Basak S, Shih VF, Hoffmann A. Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system. Mol Cell Biol 2008;28:3139-3150.
112. Bren GD, Solan NJ, Miyoshi H, Pennington KN, Pobst LJ, Paya CV. Transcription of the RelB gene is regulated by NF-kappaB. Oncogene 2001;20:7722-7733.
113. Lombardi L, et al. Structural and functional characterization of the promoter regions of the NFKB2 gene. Nucleic Acids Res 1995;23:2328-2336.
114. Stadanlick JE, et al. Tonic B-cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat Immunol 2008;9:1379-1387.
115. Otipoby KL, et al. BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B-cells. Proc Natl Acad Sci U S A 2008;105:12435-12438.
116. Patke A, Mecklenbrauker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A. BAFF controls B-cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 2006;203:2551-2562.
117. Grumont RJ, Strasser A, Gerondakis S. B-cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kappaB regulated c-myc transcription. Mol Cell 2002;10:1283-1294.
118. Kane LP, Mollenauer MN, Xu Z, Turck CW, Weiss A. Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Mol Cell Biol 2002;22:5962-5974.
119. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, Mayo MW. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 2000;20:1626-1638.
120. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999;401:82-85.
121. Ramadani F, et al. The PI3K isoforms p110alpha and p110delta are essential for pre-B-cell receptor signaling and B-cell development. Sci Signal 2010;3:ra60.
122. Debnath I, Roundy KM, Weis JJ, Weis JH. Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23. Mol Immunol 2007;44:2388-2399.
123. Gorelik L, et al. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B-cell survival function. J Immunol 2004;172:762-766.
124. Grumont RJ, Gerondakis S. The subunit composition of NF-kappa B complexes changes during B-cell development. Cell Growth Differ 1994;5:1321-1331.
125. Liou HC, Sha WC, Scott ML, Baltimore D. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol Cell Biol 1994;14:5349-5359.
126. Miyamoto S, Schmitt MJ, Verma IM. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation. Proc Natl Acad Sci U S A 1994;91:5056-5060.
127. Harhaj EW, Sun SC. Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol Cell Biol 1999;19:7088-7095.
128. Huang TT, Kudo N, Yoshida M, Miyamoto S. A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci U S A 2000;97:1014-1019.
129. Tam WF, Lee LH, Davis L, Sen R. Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export. Mol Cell Biol 2000;20:2269-2284.
130. Tam WF, Wang W, Sen R. Cell-specific association and shuttling of IkappaBalpha provides a mechanism for nuclear NF-kappaB in B lymphocytes. Mol Cell Biol 2001;21:4837-4846.
131. Wuerzberger-Davis SM, et al. Nuclear export of the NF-kappaB inhibitor IkappaBalpha is required for proper B-cell and secondary lymphoid tissue formation. Immunity 2011;34:188-200.
132. Shinohara H, Kurosaki T. Comprehending the complex connection between PKCbeta, TAK1, and IKK in BCR signaling. Immunol Rev 2009;232:300-318.
133. Ferch U, et al. MALT1 directs B-cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit. Nat Immunol 2007;8:984-991.
134. Banerjee D, Liou HC, Sen R. c-Rel-dependent priming of naive T cells by inflammatory cytokines. Immunity 2005;23:445-458.
135. Bajpai UD, Zhang K, Teutsch M, Sen R, Wortis HH. Bruton's tyrosine kinase links the B-cell receptor to nuclear factor kappaB activation. J Exp Med 2000;191:1735-1744.
136. Petro JB, Rahman SM, Ballard DW, Khan WN. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B-cell receptor engagement. J Exp Med 2000;191:1745-1754.
137. Matsuda S, et al. Critical role of class IA PI3K for c-Rel expression in B lymphocytes. Blood 2009;113:1037-1044.
138. Park SG, et al. The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells. Nat Immunol 2009;10:158-166.
139. Depoil D, et al. CD19 is essential for B-cell activation by promoting B-cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol 2008;9:63-72.
140. Tuveson DA, Carter RH, Soltoff SP, Fearon DT. CD19 of B-cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 1993;260:986-989.
141. Aiba Y, Kameyama M, Yamazaki T, Tedder TF, Kurosaki T. Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood 2008;111:1497-1503.
142. Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T. BCAP: the tyrosine kinase substrate that connects B-cell receptor to phosphoinositide 3-kinase activation. Immunity 2000;13:817-827.
143. Damdinsuren B, et al. Single round of antigen receptor signaling programs naive B-cells to receive T cell help. Immunity 2010;32:355-366.
144. Sen R, Smale ST. Selectivity of the NF-{kappa}B response. Cold Spring Harb Perspect Biol 2010;2:a000257.
145. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, Hay RT. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol 1995;15:2689-2696.
146. Arenzana-Seisdedos F, et al. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci 1997;110(Pt 3):369-378.
147. Huang TT, Miyamoto S. Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha. Mol Cell Biol 2001;21:4737-4747.
148. Johnson C, Van Antwerp D, Hope TJ. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha. EMBO J 1999;18:6682-6693.
149. Ferrarini M, Corte G, Viale G, Durante ML, Bargellesi A. Membrane Ig on human lymphocytes: rate of turnover of IgD and IgM on the surface of human tonsil cells. Eur J Immunol 1976;6:372-378.
150. Gazumyan A, Reichlin A, Nussenzweig MC. Ig beta tyrosine residues contribute to the control of B-cell receptor signaling by regulating receptor internalization. J Exp Med 2006;203:1785-1794.
151. Hinz M, Scheidereit C. Striking back at the activator: how IkappaB kinase terminates antigen receptor responses. Sci STKE 2007;2007:pe19.
152. Zeng H, et al. Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation. Mol Cell Biol 2007;27:5235-5245.
153. Harhaj EW, Dixit VM. Deubiquitinases in the regulation of NF-kappaB signaling. Cell Res 2011;21:22-39.
154. Chu Y, et al. B-cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood 2011;117:2227-2236.
155. Hovelmeyer N, et al. A20 deficiency in B-cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol 2011;41:595-601.
156. Tavares RM, et al. The ubiquitin modifying enzyme A20 restricts B-cell survival and prevents autoimmunity. Immunity 2010;33:181-191.
157. Hovelmeyer N, et al. Regulation of B-cell homeostasis and activation by the tumor suppressor gene CYLD. J Exp Med 2007;204:2615-2627.
158. Jin W, et al. Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B-cells. J Biol Chem 2007;282:15884-15893.
159. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B-cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001;2:1126-1132.
160. Reif K, et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002;416:94-99.
161. de Alboran IM, et al. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 2001;14:45-55.
162. Meyer-Bahlburg A, Bandaranayake AD, Andrews SF, Rawlings DJ. Reduced c-myc expression levels limit follicular mature B-cell cycling in response to TLR signals. J Immunol 2009;182:4065-4075.
163. Fillatreau S, Radbruch A. IRF4 - a factor for class switching and antibody secretion. Nat Immunol 2006;7:704-706.
164. Kontgen F, et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 1995;9:1965-1977.
165. Owyang AM, et al. c-Rel is required for the protection of B-cells from antigen receptor-mediated, but not Fas-mediated, apoptosis. J Immunol 2001;167:4948-4956.
166. Venkataraman L, Burakoff SJ, Sen R. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J Exp Med 1995;181:1091-1099.
167. Venkataraman L, Francis DA, Wang Z, Liu J, Rothstein TL, Sen R. Cyclosporin-A sensitive induction of NF-AT in murine B-cells. Immunity 1994;1:189-196.
168. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003;17:2205-2232.
169. Lynch J, et al. Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca(2+)-dependent signaling cascade. J Cell Biol 2005;170:37-47.
170. Neilson J, Stankunas K, Crabtree GR. Monitoring the duration of antigen-receptor occupancy by calcineurin/glycogen-synthase-kinase-3 control of NF-AT nuclear shuttling. Curr Opin Immunol 2001;13:346-350.
171. Wilker PR, et al. Transcription factor Mef2c is required for B-cell proliferation and survival after antigen receptor stimulation. Nat Immunol 2008;9:603-612.
172. Grumont R, Lock P, Mollinari M, Shannon FM, Moore A, Gerondakis S. The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-kappaB-dependent c-myc expression. Immunity 2004;21:19-30.
173. Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 2009;229:152-172.
174. Rickert RC, Jellusova J, Miletic AV. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev 2011;244:115-133.
175. Zarnegar B, He JQ, Oganesyan G, Hoffmann A, Baltimore D, Cheng G. Unique CD40-mediated biological program in B-cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Proc Natl Acad Sci U S A 2004;101:8108-8113.
176. Shih VF, Kearns JD, Basak S, Savinova OV, Ghosh G, Hoffmann A. Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity. Proc Natl Acad Sci U S A 2009;106:9619-9624.
177. Werner SL, Barken D, Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 2005;309:1857-1861.
178. Pohl T, et al. The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B-cell lineage are restricted to the activation and function of mature cells. Proc Natl Acad Sci U S A 2002;99:4514-4519.
179. Jain A, et al. Specific NEMO mutations impair CD40-mediated c-Rel activation and B-cell terminal differentiation. J Clin Invest 2004;114:1593-1602.
180. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 1986;47:921-928.
181. Gerondakis S, Grumont RJ, Banerjee A. Regulating B-cell activation and survival in response to TLR signals. Immunol Cell Biol 2007;85:471-475.
182. Banerjee A, Grumont R, Gugasyan R, White C, Strasser A, Gerondakis S. NF-kappaB1 and c-Rel cooperate to promote the survival of TLR4-activated B-cells by neutralizing Bim via distinct mechanisms. Blood 2008;112:5063-5073.